Zatebradine

This classification denotes an antiarrhythmic agent with the molecular formula C26H36N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) TV27RY5876, chemically known as 3-(3-((3,4-dimethoxyphenethyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-2h-3-benzazepin-2-one but more generally known as zatebradine, which bears US NIH Compound Identifier 65637. European Medicines Agency schedules Zatebradine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00143MIG. The term ZATEBRADINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 4, No. 3 1990, List 30). ZATEBRADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule zatebradine under HS 29337900 and SITC 51561. As of Q4 2014, ZATEBRADINE remains US FDA's Preferred Term for this commodity. Zatebradine bears US NLM identifiers UMLS ID C0208084 and NCI Concept Code C66687. SMILES: O=C1N(CCC2C(C1)CC(OC)C(OC)C2)CCCN(CCC1CC(OC)C(OC)CC1)C.